LUPRON DEPOT Drug Patent Profile
✉ Email this page to a colleague
When do Lupron Depot patents expire, and when can generic versions of Lupron Depot launch?
Lupron Depot is a drug marketed by Abbvie Endocrine Inc and is included in five NDAs. There are two patents protecting this drug.
This drug has thirty-five patent family members in twenty-eight countries.
The generic ingredient in LUPRON DEPOT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lupron Depot
A generic version of LUPRON DEPOT was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LUPRON DEPOT?
- What are the global sales for LUPRON DEPOT?
- What is Average Wholesale Price for LUPRON DEPOT?
Summary for LUPRON DEPOT
International Patents: | 35 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 133 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LUPRON DEPOT |
What excipients (inactive ingredients) are in LUPRON DEPOT? | LUPRON DEPOT excipients list |
DailyMed Link: | LUPRON DEPOT at DailyMed |
![LUPRON DEPOT drug patent expirations Drug patent expirations by year for LUPRON DEPOT](/p/graph/s/t/LUPRON_DEPOT-patent-expirations.png)
![Drug Prices for LUPRON DEPOT](/p/graph/drug-price/LUPRON+DEPOT.png)
Recent Clinical Trials for LUPRON DEPOT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Panbela Therapeutics | Phase 2 |
Prostate Cancer Foundation | Phase 2 |
Emory University | Phase 4 |
US Patents and Regulatory Information for LUPRON DEPOT
LUPRON DEPOT is protected by one US patents.
Patents protecting LUPRON DEPOT
Sustained-release composition and method for producing the same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: PALLIATIVE TREATMENT OF PROSTATE CANCER
Expired US Patents for LUPRON DEPOT
International Patents for LUPRON DEPOT
See the table below for patents covering LUPRON DEPOT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 1330293 | ⤷ Sign Up | |
Ecuador | SP099439 | COMPOSICIÓN DE LIBERACIÓN SOSTENIDA Y MÉTODOS PARA PRODUCIRLA | ⤷ Sign Up |
Germany | 69322917 | ⤷ Sign Up | |
Singapore | 180015 | CONTROLLED RELEASE COMPOSITION AND METHOD OF PRODUCING THE SAME | ⤷ Sign Up |
Brazil | 9103553 | ⤷ Sign Up | |
Germany | 3477732 | ⤷ Sign Up | |
Austria | 39935 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |